Celexocib (200 MG/D) or diclofenac (100 MG/D) in osteoarthritis: A multicentre, double blind trial

Basit Öğe Kaydı
dc.contributor.authorYazici, H
dc.contributor.authorOzdemir, O
dc.contributor.authorKirazli, Y
dc.contributor.authorOzbek, S
dc.contributor.authorOzerbil, O
dc.contributor.authorGur, A
dc.contributor.authorAral, O
dc.date.accessioned2026-08-12T18:12:54Z
dc.date.issued2003
dc.departmentFırat Üniversitesi
dc.descriptionAnnual European Congress of Rheumatology -- JUN 18, 2003 -- LISBON, PORTUGAL
dc.description.abstract[Abstract Not Available]
dc.identifier.endpage260
dc.identifier.issn0003-4967
dc.identifier.startpage260
dc.identifier.urihttps://hdl.handle.net/11508/64117
dc.identifier.volume62
dc.identifier.wosWOS:000224551400849
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.language.isoen
dc.publisherB M J Publishing Group
dc.relation.ispartofAnnals of the Rheumatic Diseases
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WoS_20260511
dc.titleCelexocib (200 MG/D) or diclofenac (100 MG/D) in osteoarthritis: A multicentre, double blind trial
dc.typeConference Object

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu